(Q53566840)

15 May 2018

title

Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma. (English)

1 reference

15 May 2018

author name string

Birgitta Clinchy

1

1 reference

15 May 2018

Annelie Fransson

2

1 reference

15 May 2018

Bengt Druvefors

3

1 reference

15 May 2018

Anna Hellsten

4

1 reference

15 May 2018

Annika Håkansson

5

1 reference

15 May 2018

Bertil Gustafsson

6

1 reference

15 May 2018

Rune Sjödahl

7

1 reference

15 May 2018

Leif Håkansson

8

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 May 2007

1 reference

15 May 2018

published in

Cancer

1 reference

15 May 2018

volume

109

1 reference

15 May 2018

issue

9

1 reference

15 May 2018

page(s)

1742-1749

1 reference

15 May 2018

Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

Prognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Molecular markers in prognosis of colorectal cancer and prediction of response to treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Gene expression profiling for molecular staging and prognosis prediction in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Lymphocytic infiltration and survival in rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Interleukin-6: a comprehensive review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Interleukin-6 and the network of several cytokines in multiple myeloma: an overview of clinical and experimental data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Circulating interleukin-6 predicts survival in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Prognostic significance of immunological evaluation in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Immunomodulatory changes in patients with colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Serum interleukin-6 levels reflect the disease status of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Intra-tumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Increased production of tumor necrosis factor and prostaglandin E2 by monocytes in cancer patients and its unique modulation by their plasma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Decreased production of interleukin-12 and type 2 immune responses are marked in cachectic patients with colorectal and gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22623

7 January 2021

Identifiers

DOI

10.1002/CNCR.22623

1 reference

15 May 2018

1 reference

15 May 2018